Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2026-01-07 @ 4:34 AM
Study NCT ID:
NCT03303794
Status:
TERMINATED
Last Update Posted:
2020-03-20
First Post:
2017-09-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
0.25% Bupivacaine Versus a Mixture of 0.25% Bupivacaine and 1.3 % Liposomal Bupivacaine in Patients Undergoing Tka
Sponsor:
Montefiore Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2017-7893
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None